A New Investigator Program grant was awarded to Rebecca Richards to investigate engineered cells to more effectively treat acute myeloid leukemia

Rebecca Richards, MD, PhD, assistant professor, Division of Hematology, Oncology, and Bone Marrow Transplant, is the recipient of one of eight New Investigator Program grants from the Wisconsin Partnership Program (WPP). Her project is entitled, “Engineering CAR T Cells to Overcome Variable Antigen Density in Acute Myeloid Leukemia.” Her proposed research seeks to optimize tumor-specific cytotoxicity utilizing precision methods to better treat acute myeloid leukemia (AML). AML is difficult to cure and affects thousands of people each year. Richards is the leader of the Richards Research Group. WPP New Investigator grants in the amount of $150,000 each are awarded to faculty members undertaking research to prevent, diagnose, treat, and cure diseases. The project will begin in July of this year and continue through June 2026.

Read more about the research funded through the WPP’s spring 2024 New Investigator Program grants in the article, “Wisconsin Partnership Program Awards $1.2 Million through New Investigator Program,” published on March 15, 2024, by the WPP.